silevine

Brand, digital & social media mixologist, marketer, photography, Sox, tech enthusiast. Global Head of Corporate Brand & Creative at @alnylam. Views are my own.

[BiotechTV @BiotechTV]

𝐔.𝐒. 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐒𝐮𝐦𝐦𝐢𝐭: Last official event of the Science Summit for our visiting communicators. Breakfast at @Alnylam!

[Alnylam Pharmaceuticals @Alnylam]

Cells use messenger RNA (mRNA) to carry instructions from DNA to make proteins. Sometimes, unwanted proteins cause or contribute to disease. #RNAi therapeutics disrupt this process by targeting specific mRNA molecules and preventing the production of disease-associated proteins.

[Alnylam Pharmaceuticals @Alnylam]

The Alnylam #BioVentureChallenge brings emerging biotech entrepreneurs together to pitch bold ideas, gain feedback from our leaders, and compete for early-stage funding.

Read more about the program, our partnership with Nucleate, and the 2025 competition: https://t.co/Qardj9c5Wo

[Alnylam Pharmaceuticals @Alnylam]

Less than 1% of drug ideas become approved medicines. Human genetic insights can improve those odds. We've recently partnered with Alliance for Genomic Discovery, FinnGen, and PRECISE Singapore to deepen our access to diverse genetic data to fuel drug development.

#RNAi

[Alnylam Pharmaceuticals @Alnylam]

Living with disease is noisy. The sounds of doctor visits, tests, managing medication, and declining things you want to do can mute the joy of life. But what happens when disease is silenced?

#SilenceDisease #AmplifyLife #RNAi #RNAiTherapeutics

[Alnylam Pharmaceuticals @Alnylam]

We believe all patients, regardless of their diagnosis, have the potential to benefit from the promise that #RNAiTherapeutics hold to #SilenceDisease and #AmplifyLife. That’s why we’ve pioneered this innovative approach and are working to bring it to as many patients as possible.

[Alnylam Pharmaceuticals @Alnylam]

#RNA researchers! Submit your abstract - https://t.co/1UAFYkgF1K - by Oct 10 to present at Cracking the Code: Nucleic Acid Medicines Coming of Age, a @Nature conference we’re co-organizing with @ionispharma & @harvardstemcell.

Attend: https://t.co/2ibbHAB2Uz

#siRNA #RNAi

[Alnylam Pharmaceuticals @Alnylam]

We're honored to be recognized as a #Humankind100 company for 2025! This continued recognition reflects our commitment to making a positive impact through our #RNAi therapeutics and community engagement.

Learn more about this recognition: https://t.co/SMsEN3VZfZ

[Alnylam Pharmaceuticals @Alnylam]

Excited to sponsor the 2025 MassBioEd Life Sciences Workforce Conference on June 3 at BU. As a Mass-based employer, we’re committed to growing the local life sciences talent pipeline.

#LifeSciences #WorkforceDevelopment

[Alnylam Pharmaceuticals @Alnylam]

Congratulations to our own Samip Dhakal, who joined the Timmerman Traverse for @DamonRunyon Cancer Research Foundation and reached #Everest Base Camp! We're #AlnylamProud to have sponsored Samip, part of a team that helped raise over $700K for #CancerResearch. #biotech

[Alnylam Pharmaceuticals @Alnylam]

We’re proud to support the Massachusetts Science & Engineering Fair and celebrate future scientists. This year, the Alnylam Bioscience Excellence Award went to Adrita Samanta, recognizing innovation and curiosity in STEM. #STEM #FutureScientists

[Alnylam Pharmaceuticals @Alnylam]

Later this month, Samip Dhakal, a Nepal native & dedicated employee, will trek to Everest Base Camp to raise $50K for @DamonRunyon. Stay tuned for his inspiring journey & updates! #CancerResearch

[Alnylam Pharmaceuticals @Alnylam]

Living with disease is noisy. The sounds of endless doctor visits, tests, managing medication and having to decline invitations to do things you really want to do...these sounds mute the joy of life. But what happens when disease is silenced?

#SilenceDisease #AmplifyLife #RNAi

[Alnylam Pharmaceuticals @Alnylam]

We’re honored to be named one of America’s Most Responsible Companies by @Newsweek for the 3rd year! This reflects our commitment to patients, communities, and sustainability. Learn more: https://t.co/eJe0hVrrvE

#CorporateResponsibility #ESG #Sustainability

[Alnylam Pharmaceuticals @Alnylam]

Yesterday from #JPM25, our CEO Yvonne Greenstreet joined @CNBC's @Angelica Peebles to talk about the continued advancement of our #RNAiTherapeutics platform, deep pipeline and what's next for Alnylam in 2025. https://t.co/HWGO9KRUnt

#RNAi #siRNA #biotechnology #biotech

[Alnylam Pharmaceuticals @Alnylam]

It's her big game. You want to be there AND be fully present. Living with disease makes that difficult by holding you back. Over time, the sounds of disease - doctor visits, tests, managing medication - mute the joy of life. But what happens when you #SilenceDisease? #AmplifyLife

[Alnylam Pharmaceuticals @Alnylam]

Living with disease is noisy. The sounds of endless doctor visits, tests, managing medication and having to decline invitations to the things you really want to do...these sounds mute the joy of life. But what happens when disease is silenced? #SilenceDisease #AmplifyLife #RNAi

[Alnylam Pharmaceuticals @Alnylam]

As a company driven by #science, it's important to us to be regarded by our peers as a great place for scientists to work. That's why we're so deeply honored to be named a @ScienceMagazine Top Place to Work for 2024 - our 6th year in a row on this list! #SCTopEmployers

[Alnylam Pharmaceuticals @Alnylam]

This World Alzheimer’s Month, learn about #AlzheimersDisease (AD) and dementia. We're working with urgency to explore the potential for our RNAi therapeutics in helping to change the outlook for people living with AD. #WorldAlzMonth

[Alnylam Pharmaceuticals @Alnylam]

Developers use operating systems like iOS or Android to quickly and easily create new apps. We use our #RNAiTherapeutics platform similarly to quickly develop investigational medicines. A new @NaturePortfolio article (sponsored content; for US audiences only) explains how. #RNAi